Thyroid hormone deiodinases and cancer

Frontiers in Endocrinology

Volumn 3, Issue JUN, 2012, Pages

  Casula, Sabina ^a   Bianco, Antonio C ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Deiodinase; Thyroid

Indexed keywords

EID: 84874565728     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2012.00074     Document Type: Article

References (85)

1. Alexander, E. K., Marqusee, E., Lawrence, J., Jarolim, P., Fischer, G. A., and Larsen, P. R. (2003). "Time of onset and magnitude of increase in levothyroxine requirements during pregnancy in women with hypothyroidism," in 75th Annual Meeting of the American Thyroid Association, Palm Beach, FL.
2. Ambroziak, M., Pachucki, J., Stachlewska-Nasfeter, E., Nau-man, J., and Nauman, A. (2005). Disturbed expression of type 1 and type 2 iodothyronine deiodinase as well as titf1/nkx2-1 and pax-8 transcription factor genes in pap-illary thyroid cancer. Thyroid 15, 1137-1146.
3. Araki, O., Murakami, M., Morimura, T., Kamiya, Y., Hosoi, Y., Kato, Y., and Mori, M. (1999). Assignment of type II iodothyronine deiodinase gene (DIO2) to human chromosome band 14q24.2 ->q24.3 by in situ hybridization. Cytogenet. Cell Genet. 84, 73-74.
4. Arnaldi, L. A., Borra, R. C., Maciel, R. M., and Cerutti, J. M. (2005). Gene expression profiles reveal that DCN, DIO1, and DIO2 are under-expressed in benign and malig-nant thyroid tumors. Thyroid 15, 210-221.
5. Balazs, A. E., Athanassaki, I., Gunn, S. K., Tatevian, N., Huang, S. A., Haymond, M. W., and Karaviti, L. P. (2007). Rapid resolution of consumptive hypothyroidism in a child with hepatic hemangioen-dothelioma following liver trans-plantation. Ann. Clin. Lab. Sci. 37, 280-284.
6. Bartha, T., Kim, S. W., Salvatore, D.,Gereben,B.,Tu,H.M.,Har-ney, J. W., Rudas, P., and Larsen, P. R. (2000). Characterization of the 5′-flanking and 5′-untranslated regions of the cyclic adenosine 3′,5′-monophosphate-responsive human type 2 iodothyronine deiodinase gene. Endocrinology 141, 229-237.
7. Bates, J. M., St Germain, D. L., and Gal-ton, V. A. (1999). Expression pro-files of the three iodothyronine deio-dinases, D1, D2, and D3, in the developing rat. Endocrinology 140, 844-851.
8. Baur, A., Buchfelder, M., and Kohrle, J. (2002). Expression of 5′-deiodinase enzymes in normal pituitaries and in various human pituitary adenomas. Eur. J. Endocrinol. 147, 263-268.
9. Bianco, A. C., Maia, A. L., da Silva, W. S., and Christoffolete, M. A. (2005). Adaptive activation of thy-roid hormone and energy expendi-ture. Biosci. Rep. 25, 191-208.
10. Bianco, A. C., Salvatore, D., Gereben, B., Berry, M. J., and Larsen, P. R. (2002). Biochemistry, cellular and molecu-lar biology and physiological roles of the iodothyronine selenodeiodi-nases. Endocr. Rev. 23, 38-89.
11. Boguslawska, J., Wojcicka, A., Piekielko-Witkowska, A., Master, A., and Nau-man, A. (2011). MiR-224 targets the 3′UTR of type 1 5′-iodothyronine deiodinase possibly contributing to tissue hypothyroidism in renal cancer. PLoS ONE 6, e24541. doi:10.1371/journal.pone.0024541.
12. Callebaut, I., Curcio-Morelli, C., Mornon, J. P., Gereben, B., Buettner, C., Huang, S., Castro, B., Fonseca, T. L., Harney, J. W., Larsen, P. R., and Bianco, A. C. (2003). The iodothyronine selenodeiodinases are thioredoxin-fold family proteins containing a glycoside hydrolase clan GH-A-like structure. J. Biol. Chem. 278, 36887-36896.
13. Canettieri, G., Celi, F. S., Baccheschi, G., Salvatori, L., Andreoli, M., and Cen-tanni, M. (2000). Isolation of human type 2 deiodinase gene promoter and characterization of a func-tional cyclic adenosine monophos-phate response element. Endocrinol-ogy 141, 1804-1813.
14. Celi, F. S., Canettieri, G., Yarnall, D. P., Burns, D. K., Andreoli, M., Shuldiner, A. R., and Centanni, M. (1998). Genomic characterization of the coding region of the human type II 5′-deiodinase gene. Mol. Cell. Endocrinol. 141, 49-52.
15. Christoffolete, M. A., Ribeiro, R., Sin-gru, P., Fekete, C., da Silva, W. S., Gordon, D. F., Huang, S. A., Crescenzi,A.,Harney,J. W.,Ridgway, E. C., Larsen, P. R., Lechan, R. M., and Bianco, A. C. (2006). Atypical expression of type 2 iodothyronine deiodinase in thyrotrophs explains the thyroxine-mediated pituitary thyrotropin feedback mechanism. Endocrinology 147, 1735-1743.
16. Curcio, C., Baqui, M. M., Salvatore, D., Rihn, B. H., Mohr, S., Harney, J. W., Larsen, P. R., and Bianco, A. C. (2001). The human type 2 iodothy-ronine deiodinase is a selenopro-tein highly expressed in a mesothe-lioma cell line. J. Biol. Chem. 276, 30183-30187.
17. da-Silva, W. S., Harney, J. W., Kim, B. W., Li, J., Bianco, S. D., Crescenzi, A., Christoffolete, M. A., Huang, S. A., and Bianco, A. C. (2007). The small polyphenolic molecule kaempferol increases cellular energy expendi-ture and thyroid hormone activa-tion. Diabetes 56, 767-776.
18. de Souza Meyer, E. L., Dora, J. M., Wagner, M. S., and Maia, A. L. (2005). Decreased type 1 iodothyro-nine deiodinase expression might be an early and discrete event in thyroid cell dedifferentiation towards pap-illary carcinoma. Clin. Endocrinol. (Oxf.) 62, 672-678.
19. Debski, M. G., Pachucki, J., Ambroziak, M., Olszewski, W., and Bar-Andziak, E. (2007). Human breast cancer tis-sue expresses high level of type 1 5′-deiodinase. Thyroid 17, 3-10.
20. Dentice, M., Bandyopadhyay, A., Gereben, B., Callebaut, I., Christof-folete, M. A., Kim, B. W., Nissim, S., Mornon, J. P., Zavacki, A. M., Zeold, A., Capelo, L. P., Curcio-Morelli, C., Ribeiro, R., Harney, J. W., Tabin, C. J., and Bianco, A. C. (2005). The Hedgehog-inducible ubiquitin ligase subunit WSB-1 modulates thyroid hormone activation and PTHrP secretion in the developing growth plate. Nat. Cell Biol. 7, 698-705.
21. Dentice, M., Luongo, C., Huang, S., Ambrosio, R., Elefante, A., Mirebeau-Prunier, D., Zavacki, A. M., Fenzi, G., Grachtchouk, M., Hutchin, M., Dlugosz, A. A., Bianco, A. C., Missero, C., Larsen, P. R., and Salvatore, D. (2007). Sonic hedgehog-induced type 3 deiodi-nase blocks thyroid hormone action enhancing proliferation of nor-mal and malignant keratinocytes. Proc. Natl. Acad. Sci. U.S.A. 104, 14466-14471.
22. Dentice, M., Marsili, A., Ambrosio, R., Guardiola, O., Sibilio, A., Paik, J. H., Minchiotti, G., DePinho, R. A., Fenzi, G., Larsen, P. R., and Salva-tore, D. (2011). The FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and mus-cle regeneration. J. Clin. Invest. 120, 4021-4030.
23. Dentice, M., Morisco, C., Vitale, M., Rossi, G., Fenzi, G., and Salvatore, D. (2003). The different cardiac expres-sion of the type 2 iodothyronine deiodinase gene between human and rat is related to the differ-ential response of the Dio2 genes to Nkx-2.5 and GATA-4 transcrip-tion factors. Mol. Endocrinol. 17, 1508-1521.
24. Dutkiewicz, S., Witeska, A., and Nau-man, A. (1995). The deiodination of thyroxine to triiodothyronine in the testes of patients with prostate cancer. Int. Urol. Nephrol. 27, 81-85.
25. Fekete, C., Sarkar, S., Christoffolete, M. A., Emerson, C. H., Bianco, A. C., and Lechan, R. M. (2005). Bacterial lipopolysaccharide (LPS)-induced type 2 iodothyronine deio-dinase (D2) activation in the mediobasal hypothalamus (MBH) is independent of the LPS-induced fall in serum thyroid hormone levels. Brain Res. 1056, 97-99.
26. Freitas, B. C., Gereben, B., Castillo, M., Kallo, I., Zeold, A., Egri, P., Liposits, Z., Zavacki, A. M., Maciel, R. M., Jo, S., Singru, P., Sanchez, E., Lechan, R. M., and Bianco, A. C. (2010). Paracrine signaling by glial cell-derived triiodothyronine acti-vates neuronal gene expression in the rodent brain and human cells. J. Clin. Invest. 120, 2206-2217.
27. Galton, V. A., Schneider, M., Clark, A. S., and Germain, D. L. (2009). Life without T4 to T3 conversion: studies in mice devoid of the 5′-deiodinases. Endocrinology 150, 2957-2963.
28. Garcia-Solis, P., and Aceves, C. (2003). 5′Deiodinase in two breast cancer cell lines: effect of triiodothyronine, isoproterenol and retinoids. Mol. Cell. Endocrinol. 201, 25-31.
29. Gereben, B., and Bianco, A. C. (2009). Covering the base-pairs in iodothy-ronine deiodinase-1 biology: holes remain in the lineup. Thyroid 19, 1027-1029.
30. Gereben, B., Salvatore, D., Harney, J. W., Tu, H. M., and Larsen, P. R. (2001). The human, but not rat, dio2 gene is stimulated by thyroid transcription factor-1 (TTF-1). Mol. Endocrinol. 15, 112-124.
31. Gereben, B., Zavacki, A. M., Ribich, S., Kim, B. W., Huang, S. A., Simonides, W. S., Zeold, A., and Bianco, A. C. (2008). Cellular and molecular basis of deiodinase-regulated thy-roid hormone signaling. Endocr. Rev. 29, 898-938.
32. Gouveia, C. H., Christoffolete, M. A., Zaitune, C. R., Dora, J. M., Harney, J. W., Maia, A. L., and Bianco, A. C. (2005). Type 2 iodothyronine selenodeiodinase is expressed throughout the mouse skeleton and in the MC3T3-E1 mouse osteoblastic cell line during differentiation. Endocrinology 146, 195-200.
33. Grozovsky, R., Ribich, S., Rosene, M. L., Mulcahey, M. A., Huang, S. A., Patti, M. E., Bianco, A. C., and Kim, B. W. (2009). Type 2 deio-dinase expression is induced by peroxisomal proliferator-activated receptor-gamma agonists in skele-tal myocytes. Endocrinology 150, 1976-1983.
34. Hall, J. A., Ribich, S., Cristoffolete, M. A., Simovic, G., Correa, M., Patti, M. E., and Bianco, A. C. (2010). Absence of thyroid hormone acti-vation during development under-lies a permanent defect in adaptive thermogenesis. Endocrinology 151, 4573-4582.
35. Hernandez, A. (2005). Structure and function of the type 3 deiodinase gene. Thyroid 15, 865-874.
36. Hernandez, A., Lyon, G. J., Schneider, M. J., and St Germain, D. L. (1999). Isolation and characterization of the mouse gene for the type 3 iodothyro-nine deiodinase. Endocrinology 140, 124-130.
37. Hernandez, A., and Obregon, M. J. (1995). Presence of growth factors-induced type III iodothy-ronine 5-deiodinase in cultured rat brown adipocytes. Endocrinology 136, 4543-4550.
38. Hernandez, A., Park, J. P., Lyon, G. J., Mohandas, T. K., and St Ger-main, D. L. (1998). Localization of the type 3 iodothyronine deiodi-nase (DIO3) gene to human chro-mosome 14q32 and mouse chromo-some 12F1. Genomics 53, 119-121.
39. Hernandez, A., and St Germain, D. L. (2002). Dexamethasone inhibits growth factor-induced type 3 deiod-inase activity and mRNA expression in a cultured cell line derived from rat neonatal brown fat vascular-stromal cells. Endocrinology 143, 2652-2658.
40. Hernandez, A., and St Germain, D. L. (2003). Activity and response to serum of the mammalian thyroid hormone deiodinase 3 gene pro-moter: identification of a conserved enhancer. Mol. Cell. Endocrinol. 206, 23-32.
41. Huang, S. A. (2005). Physiology and pathophysiology of type 3 deio-dinase in humans. Thyroid 15, 875-881.
42. Huang, S. A., and Bianco, A. C. (2008). Reawakened interest in type III iodothyronine deiodinase in critical illness and injury. Nat. Clin. Pract. Endocrinol. Metab. 4, 148-155.
43. Huang, S. A., Dorfman, D. M., Gen-est, D. R., Salvatore, D., and Larsen, P. R. (2003). Type 3 iodothyronine deiodinase is highly expressed in the human uteroplacental unit and in fetal epithelium. J. Clin. Endocrinol. Metab. 88, 1384-1388.
44. Huang, S. A., Mulcahey, M. A., Crescenzi, A., Chung, M., Kim, B., Barnes, C. A., Kuijt, W., Tu, H. M., Harney, J. W., and Larsen, P. R. (2005). TGF-B promotes inactiva-tion of extracellular thyroid hor-mones via transcriptional stimu-lation of type 3 iodothyronine deiodinase. Mol. Endocrinol. 19, 3126-3136.
45. Huang, S. A., Tu, H. M., Harney, J. W., Venihaki, M., Butte, A. J., Kozakewich, H. P., Fishman, S. J., and Larsen, P. R. (2000). Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infan-tile hemangiomas. N.Engl.J.Med. 343, 185-189.
46. Jakobs, T. C., Koehler, M. R., Schmut-zler, C., Glaser, F., Schmid, M., and Kohrle, J. (1997a). Structure of the human type I iodothyronine 5′-deiodinase gene and localization to chromosome 1p32-p33. Genomics 42, 361-363.
47. Jakobs, T. C., Schmutzler, C., Meiss-ner, J., and Kohrle, J. (1997b). The promoter of the human type I 5′-deiodinase gene -mapping of the transcription start site and identifi-cation of a DR+4 thyroid-hormone-responsive element. Eur. J. Biochem. 247, 288-297.
48. Kester, M. H., Kuiper, G. G., Versteeg, R., and Visser, T. J. (2006). Regula-tion of type III iodothyronine deiod-inase expression in human cell lines. Endocrinology 147, 5845-5854.
49. Kim, B. W., Daniels, G. H., Harrison, B. J., Price, A., Harney, J. W., Larsen, P. R., and Weetman,A. P. (2003). Over-expression of type 2 iodothyronine deiodinase in follicular carcinoma as a cause of low circulating free thyroxine levels. J. Clin. Endocrinol. Metab. 88, 594-598.
50. Kim, S. W., Harney, J. W., and Larsen, P. R. (1998). Studies of the hormonal regulation of type 2 5′-iodothyronine deiodinase mes-senger ribonucleic acid in pituitary tumor cells using semiquantitative reverse transcription-polymerase chain reaction. Endocrinology 139, 4895-4905.
51. Koppenol, W. H., Bounds, P. L., and Dang, C. V. (2011). Otto Warburg's contributions to current concepts of cancer metabolism. Nat. Rev. Cancer 11, 325-337.
52. Larsen, P. R., Silva, J. E., and Kaplan, M. M. (1981). Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications. Endocr. Rev. 2, 87-102.
53. Luk, J. M., Burchard, J., Zhang, C., Liu, A. M., Wong, K. F., Shek, F. H., Lee, N. P., Fan, S. T., Poon, R. T., Ivanovska, I., Philippar, U., Cleary, M. A., Buser, C. A., Shaw, P. M., Lee, C. N., Tenen, D. G., Dai, H., and Mao, M. (2011). DLK1-DIO3 genomic imprinted microRNA clus-ter at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival. J. Biol. Chem. 286, 30706-30713.
54. Macejova, D., Liska, J., and Brtko, J. (2001). Mammary gland carcinoma-related increase of type I iodothy-ronine 5′-deiodinase activity in Sprague-Dawley rats. Gen. Physiol. Biophys. 20, 293-302.
55. Meyer, E. L., Goemann, I. M., Dora, J. M., Wagner, M. S., and Maia, A. L. (2008). Type 2 iodothyronine deiodinase is highly expressed in medullary thyroid carcinoma. Mol. Cell. Endocrinol. 289, 16-22.
56. Meyer, E. L., Wagner, M. S., and Maia, A. L. (2007). Iodothyronine deiodinases expression in thyroid neoplasias. Arq. Bras. Endocrinol. Metabol. 51, 690-700.
57. Mori, K., Yoshida, K., Kayama, T., Kaise, N., Fukazawa, H., Kiso, Y., Kikuchi, K., Aizawa, Y., and Abe, K. (1993). Thyroxine 5-deiodinase in human brain tumors. J. Clin. Endocrinol. Metab. 77, 1198-1202.
58. Morimura, T., Tsunekawa, K., Kasahara, T., Seki, K., Ogiwara, T., Mori, M., and Murakami, M. (2005). Expres-sion of type 2 iodothyronine deiod-inase in human osteoblast is stimu-lated by thyrotropin. Endocrinology 146, 2077-2084.
59. Murakami, M., Araki, O., Hosoi, Y., Kamiya, Y., Morimura, T., Ogiwara, T.,Mizuma,H.,and Mori,M. (2001). Expression and regulation of type II iodothyronine deiodinase in human thyroid gland. Endocrinology 142, 2961-2967.
60. Murakami, M., Araki, O., Morimura, T., Hosoi, Y., Mizuma, H., Yamada, M., Kurihara, H., Ishiuchi, S., Tamura, M., Sasaki, T., and Mori, M. (2000). Expression of type II iodothyronine deiodinase in brain tumors. J. Clin. Endocrinol. Metab. 85, 4403-4406.
61. Nauman, P., Bonicki, W., Michalik, R., Warzecha, A., and Czernicki, Z. (2004). The concentration of thyroid hormones and activities of iodothyronine deiodinases are altered in human brain gliomas. Folia Neuropathol. 42, 67-73.
62. Olivares, E. L., Marassi, M. P., Fortu-nato, R. S., da Silva, A. C., Costa-e-Sousa, R. H., Araujo, I. G., Mat-tos, E. C., Masuda, M. O., Mulca-hey, M. A., Huang, S. A., Bianco, A. C., and Carvalho, D. P. (2007). Thy-roid function disturbance and type 3 iodothyronine deiodinase induction after myocardial infarction in rats a time course study. Endocrinology 148, 4786-4792.
63. Pachucki, J., Ambroziak, M., Tanski, Z., Luczak, J., Nauman, J., and Nauman, A. (2001). Type I 5′-iodothyronine deiodinase activity and mRNA are remarkably reduced in renal clear cell carcinoma. J. Endocrinol. Invest. 24, 253-261.
64. Pallud, S., Ramauge, M., Gavaret, J. M., Lennon, A. M., Munsch, N., St Germain, D. L., Pierre, M., and Courtin, F. (1999). Regulation of type 3 iodothyronine deiodinase expression in cultured rat astrocytes: role of the Erk cascade. Endocrinol-ogy 140, 2917-2923.
65. Peeters, R., Fekete, C., Goncalves, C., Legradi, G., Tu, H. M., Harney, J. W., Bianco, A. C., Lechan, R. M., and Larsen, P. R. (2001). Regional physiological adaptation of the cen-tral nervous system deiodinases to iodine deficiency. Am. J. Physiol. Endocrinol. Metab. 281, E54-E61.
66. Pereira, V. S., Marassi, M. P., Rosen-thal, D., Vaisman, M., and Correa da Costa,V. M. (2011). Positive correla-tion between type 1 and 2 iodothyro-nine deiodinases activities in human goiters. Endocrine 41, 532-538.
67. Peters, C., Langham, S., Mullis, P. E., and Dattani, M. T. (2010). Use of com-bined liothyronine and thyroxine therapy for consumptive hypothy-roidism associated with hepatic hae-mangiomas in infancy. Horm. Res. Paediatr. 74, 149-152.
68. Piekielko-Witkowska, A., Master, A., Wojcicka, A., Boguslawska, J., Brozda, I., Tanski, Z., and Nauman, A. (2009). Disturbed expression of type 1 iodothyronine deiodinase splice variants in human renal cancer. Thyroid 19, 1105-1113.
69. Piekielko-Witkowska, A., and Nauman, A. (2011). Iodothyronine deiodi-nases and cancer. J. Endocrinol. Invest. 34, 716-728.
70. Pol, C. J., Muller, A., Zuidwijk, M. J., van Deel, E. D., Kaptein, E., Saba, A., Marchini, M., Zucchi, R., Visser, T. J., Paulus, W. J., Duncker, D. J., and Simonides, W. S. (2011). Left-ventricular remodeling after myocardial infarction is asso-ciated with a cardiomyocyte-specific hypothyroid condition. Endocrinol-ogy 152, 669-679.
71. Ramadan, W., Marsili, A., Huang, S., Larsen, P. R., and Silva, J. E. (2011). Type-2 iodothyronine 5′deiodinase in skeletal muscle of C57BL/6 mice. I. Identity, subcellular localization, and characterization. Endocrinology 152, 3082-3092.
72. Ruppe, M. D., Huang, S. A., and Jan de Beur, S. M. (2005). Consump-tive hypothyroidism caused by para-neoplastic production of type 3 iodothyronine deiodinase. Thyroid 15, 1369-1372.
73. Sabatino, L., Iervasi, G., Ferrazzi, P., Francesconi, D., and Chopra, I. J. (2000). A study of iodothyronine 5′-monodeiodinase activities in normal and pathological tissues in man and their comparison with activities in rat tissues. Life Sci. 68, 191-202.
74. Schreck, R., Schnieders, F., Schmutzler, C., and Kohrle, J. (1994). Retinoids stimulate type I iodothyronine 5′-deiodinase activity in human fol-licular thyroid carcinoma cell lines. J. Clin. Endocrinol. Metab. 79, 791-798.
75. Simonides, W. S., Mulcahey, M. A., Redout, E. M., Muller, A., Zuid-wijk, M. J., Visser, T. J., Wassen, F. W., Crescenzi, A., da-Silva, W. S., Harney, J., Engel, F. B., Obregon, M. J., Larsen, P. R., Bianco, A. C., and Huang, S. A. (2008). Hypoxia-inducible factor induces local thy-roid hormone inactivation during hypoxic-ischemic disease in rats. J. Clin. Invest. 118, 975-983.
76. Song, S., Adachi, K., Katsuyama, M., Sorimachi, K., and Oka, T. (2000). Isolation and characterization of the 5′-upstream and untranslated regions of the mouse type II iodothy-ronine deiodinase gene. Mol. Cell. Endocrinol. 165, 189-198.
77. St Germain, D. L. (1986). Hor-monal control of a low Km (type II) iodothyronine 5′-deiodinase in cultured NB41A3 mouse neurob-lastoma cells. Endocrinology 119, 840-846.
78. Tannahill, L. A., Visser, T. J., McCabe, C. J., Kachilele, S., Boelaert, K., Shep-pard, M. C., Franklyn, J. A., and Gittoes, N. J. (2002). Dysregulation of iodothyronine deiodinase enzyme expression and function in human pituitary tumours. Clin. Endocrinol. (Oxf.) 56, 735-743.
79. Toyoda, N., Zavacki, A. M., Maia, A. L., Harney, J. W., and Larsen, P. R. (1995). A novel retinoid X receptor-independent thyroid hor-mone response element is present in the human type 1 deiodinase gene. Mol. Cell. Biol. 15, 5100-5112.
80. Van der Geyten, S., Segers, I., Gereben, B., Bartha, T., Rudas, P., Larsen, P. R., Kuhn, E. R., and Darras, V. M. (2001). Transcriptional regulation of iodothyronine deiodinases during embryonic development. Mol. Cell. Endocrinol. 183, 1-9.
81. Wassen,F. W.,Schiel,A. E.,Kuiper,G. G., Kaptein, E., Bakker, O., Visser, T. J., and Simonides, W. S. (2002). Induc-tion of thyroid hormone-degrading deiodinase in cardiac hypertro-phy and failure. Endocrinology 143, 2812-2815.
82. Wawrzynska, L., Sakowicz, A., Rudzin-ski, P., Langfort, R., and Kurzyna, M. (2003). The conversion of thy-roxine to triiodothyronine in the lung: comparison of activity of type I iodothyronine 5′ deiodinase in lung cancer with peripheral lung tis-sues. Monaldi Arch. Chest Dis. 59, 140-145.
83. Yoshimura, T., Yasuo, S., Watanabe, M., Iigo, M., Yamamura, T., Hirunagi, K., and Ebihara, S. (2003). Light-induced hormone conversion of T4 to T3 regulates photoperiodic response of gonads in birds. Nature 426, 178-181.
84. Zeold, A., Doleschall, M., Haffner, M. C., Capelo, L. P., Menyhert, J., Liposits, Z., da Silva, W. S., Bianco, A. C., Kacskovics, I., Fekete, C., and Gereben, B. (2006). Characteriza-tion of the nuclear factor-kappa B responsiveness of the human dio2 gene. Endocrinology 147, 4419-4429.
85. Zhang, C., Kim, S., Harney, J. W., and Larsen, P. R. (1998). Further characterization of thyroid hor-mone response elements in the human type 1 iodothyronine deiodinase gene. Endocrinology 139, 1156-1163.